1. Department of Health and Human Services, Protection of Human Subjects. Revised June 23, 2005.
2. Cuzzolin, L., A. Atzei, and V. Fanos, Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf, 2006. 5(5): pp. 703–18.
3. Best Pharmaceuticals Act, in PL107-109, 2002.
4. Miller, R.P., R.J. Roberts, and L.J. Fischer, Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther, 1976. 19(3): pp. 284–94.
5. Kearns, G.L., Impact of developmental pharmacology on pediatric study design: overcoming the challenges. J Allergy Clin Immunol, 2000. 106(3 Suppl): pp. S128–38.